BMC INFECTIOUS DISEASES, vol.13, 2013 (Peer-Reviewed Journal)
Article / Article
BMC INFECTIOUS DISEASES
Science Citation Index Expanded, Scopus
Antifungal agents, Voriconazole, Liposomal amphotericin B, Economic evaluation, Invasive fungal infection, Empiric therapy, ANTIFUNGAL THERAPY, FEBRILE NEUTROPENIA, ECONOMIC-EVALUATION, PERSISTENT FEVER, CASPOFUNGIN, IMPACT
Background: Invasive fungal infections (IFI) are associated with considerable expense and mortality on healthcare systems. There is a need to provide evidence of both clinical efficacy and value for money with any health technology. The current pharmacoeconomic evaluation investigated the use of liposomal amphotericin B (LAmB) and voriconazole for the empiric treatment of IFI in the Turkish setting.